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ABSTRACT 
Aims: Conflicting evidence exists regarding whether obesity is independently associated with 
coronary artery calcium (CAC), a measure of coronary atherosclerosis. We examined an 
independent association of obesity with prevalent CAC among samples of multi-ethnic groups 
whose background populations have varying levels of obesity and coronary heart disease. 
Methods and results: We analyzed a population-based sample of 1,212 men, aged 40-49 years 
free of clinical cardiovascular disease recruited in 2002-2006; 310 Japanese in Japan (JJ), 294 
Koreans in South Korea (KN), 300 Japanese Americans (JA) and 308 Whites (UW) in the US. 
We defined prevalent CAC as an Agatston score of ≥10. Prevalent CAC was calculated by tertile 
of body mass index (BMI) in each ethnic group and was plotted against the corresponding 
median of tertile BMI. Additionally, logistic regression was conducted to examine whether an 
association of BMI was independent of conventional risk factors. Median BMI and crude 
prevalence of CAC for JJ, KN, JA, and UW were 23.4, 24.4, 27.4, and 27.1 (kg/m2); 12, 11, 32, 
and 26 (%), respectively. Despite the absolute difference in levels of BMI and CAC across 
groups, higher BMI was generally associated with higher prevalent CAC in each group. After 
adjusting for age, smoking, alcohol, hypertension, lipids, and diabetes mellitus, BMI was 
positively and independently associated with prevalent CAC in JJ, KN, UW, but not in JA. 
Conclusion: In this multi-ethnic study, obesity was independently associated with subclinical 
stage of coronary atherosclerosis among men aged 40-49 years regardless of BMI level.  
 
Keywords: coronary artery calcium, obesity, body mass index, multi-ethnic, men, risk factors 
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Introduction 
The relationship between obesity and coronary heart disease (CHD) has been well-described, and 
many researchers consider obesity as an independent risk factor for clinical CHD. However, 
others remain wary of this viewpoint as some of the well-established CHD risk factors, such as 
hypertension and diabetes mellitus, are jointly associated with obesity and thus may confound 
the true relationship between obesity and CHD.1, 2 Coronary artery calcium (CAC) is a biomarker 
for subclinical coronary atherosclerosis.3, 4 The Agatston score, which was developed to quantify 
the extent of CAC,5 is shown to correlate closely with the volume of coronary artery plaque 
measured at autopsy 6 and is considered a surrogate for the overall coronary-plaque burden.7, 8 
However, the relationship between obesity and CAC remains to be studied in depth as the 
available data document conflicting results.9-18 Furthermore, most relevant studies were 
conducted in Western populations in which CHD and obesity are more prevalent relative to other 
populations, such as East Asians.19-22 Little is known, therefore, about whether obesity is 
independently associated with CAC among leaner populations.  
 
We have previously reported that prevalence of CAC among Japanese men in Japan was 
significantly lower than that in Japanese Americans and whites in the US.23, 24 We also found that 
Japanese men in Japan had lowest of body mass index (BMI) levels of the three groups studied.25 
Thus, we were motivated to examine the relationship between obesity and CAC among 
multi-ethnic groups. The objective of this study is to examine the relationship of BMI, a 
commonly used measure of obesity, to prevalent CAC among four ethnic groups of individuals 
free of clinical cardiovascular disease; Japanese in Japan, Koreans in South Korea, Japanese 
Americans and whites in the US using standardized protocol including measurement of CAC. As 
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these populations have different levels of BMI,19, 21, 22, 26, a comparison would provide important 
clue about the role of obesity in subclinical stage of coronary atherosclerosis. 
 
Methods 
Study population 
Detailed methods for enrollment of the study participants were reported elsewhere.23, 24, 27 In 
brief, we randomly selected population-based samples of 1,228 men aged 40–49 years between 
2002 and 2006 from four centers: 313 Japanese from Kusatsu City, Shiga, Japan (JJ); 302 
Koreans from Ansan City, Gyeonggi-do, South Korea (KN); 303 Japanese Americans in 
Honolulu, Hawaii, US (JA); and 310 whites from Allegheny County, Pennsylvania, US (UW). 
None of the participants had clinical cardiovascular disease, type I diabetes, or other severe 
diseases.25 Of those, we excluded 16 individuals from the present study due to missing pertinent 
variables, leaving 1,212 for analysis (310 JJ, 295 KN, 300 JA, and 307 UW). Informed consent 
was obtained from all participants. The study protocol conforms to the ethical guidelines of the 
1975 Declaration of Helsinki, and it was approved by the Institutional Review Board of each 
study center. 
 
CAC measurement 
The detailed scanning procedures with electron-beam computed tomography were described 
elsewhere.24 In brief, scanning was performed using a standardized protocol with a GE-Imatron 
C150 EBT scanner (GE Medical Systems, South San Francisco, California). Images were 
obtained from the level of the aortic root to the apex of the heart. We considered CAC to be 
present with 3 contiguous pixels (area = 1 mm2) ≥130 Hounsfield units. One trained reader at the 
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Cardiovascular Institute, University of Pittsburgh, read the images using a 
Digital-Imaging-and-Communications in Medicine workstation and software by the AccuImage 
Diagnostic Corporation (San Francisco, California), which calculates coronary calcium score 
with the Agatston scoring method 5 (Agatston score). To define the presence of CAC, Agatston 
score ≥ 10 was used. We selected this cutoff point of 10 because of (1) its clinical significance,28 
(2) the possibility that scores ranging from > 0 to < 10 could be an imaging artifact from 
spurious noise,29 and (3) our intention to keep the consistent cutoff point with our previous 
studies.23, 24 The reader was blinded to participant’s characteristics and the study centers. The 
reproducibility of the electron beam computed tomography scans had an intraclass correlation of 
0.98.25 
 
Other measurements 
Body weight and height were measured while the participant was wearing light clothing without 
shoes. Waist circumference measured twice at the umbilical level at the end of the exhalation 
phase while the participant was standing upright, and the mean of the two measurements was 
used for analysis. Blood pressure was measured twice consecutively in the right arm of the 
seated participant after he sat quietly for 5 minutes, using an automated sphygmomanometer 
(BP-8800; Colin Medical Technology, Komaki, Japan). The average of the two measurements 
was used. Venipuncture was performed early in the clinic visit after a 12-hour fast. The samples 
from remote sites were shipped on dry ice to the University of Pittsburgh. Serum lipids were 
determined with standardized methods according to the Centers for Disease Control and 
Prevention. We estimated LDLc by the Friedewald equation for individuals with triglycerides < 
4.52 mmol/L (400 mg/dL). Otherwise, we directly measured LDLc using an automated 
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spectrophotometric assay, LDL Direct Liquid Select (Equal Diagnostics, Exton US). Serum 
glucose was determined using a hexokinase, glucose-6-phosphate-dehydrogenase, enzymatic 
assay. 
 
A self-administered questionnaire was used to obtain information on demography, including 
smoking habits (never, past, current), alcohol drinking (never, past, current), use of medication(s) 
for elevated blood pressure, lipids, and diabetes mellitus. For drinking, qualitative information 
was further queried as whether the participant drank beer, wine, liquor, sake (Japanese rice wine), 
or other alcoholic beverages. Quantity and frequency were noted. Then, ethanol consumption 
(gram per day) was estimated, assuming that concentrations of alcohol were 5 percent for beer, 
12 percent for wine, 40 percent for liquor, and 16 percent for sake.24 Diabetes mellitus was 
defined as use of anti-diabetic medication(s) or fasting glucose ≥ 7.0 mmol/L (126mg/dL). 
Hypertension was defined as use of anti-hypertensive medication(s) or systolic/diastolic blood 
pressure ≥ 140/90mmHg. 
 
Statistical analysis 
Crude and adjusted estimates of prevalent CAC (%) for each group was calculated following 
standard analysis of covariance techniques and binary logistic regression models.30 We first 
divided each ethnic group into tertiles according to BMI (kg/m2), and then plotted the median 
BMI of each tertile against the corresponding CAC prevalence. Second, we performed logistic 
regression to obtain multivariable-adjusted odds ratios (ORs) of prevalent CAC in reference to 
first BMI tertile for each ethnic group (“tertile analyses”). Third, we conducted separate logistic 
regression analyses to obtain standardized coefficients (i.e. ORs per 1 standard deviation 
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increase) of BMI and other continuous risk factors within, but not across, ethnic group(s). This 
was because we aimed to assess the magnitude of association of BMI with CAC relative to other 
risk factors within each ethnic group.  
 
We constructed the following models with regard to adjustment. In model 1, we adjusted for age 
(years) only. In model 2, we further adjusted for smoking status (never, past, current), alcohol 
drinking status (never, past, current with < 23g/day of alcohol, current with ≥ 23g/day of 
alcohol),31 serum LDLc (continuous), and use of lipid medication (yes/no) as these covariates are 
considered to be associated with CAC independent of obesity.9, 12, 31 In model 3, we further 
adjusted for diabetes mellitus (yes/no) and hypertension (yes/no). In model 4, we added serum 
levels (continuous) of HDLc and natural log transformed triglycerides (lnTG). We recognized a 
priori that models 3 and 4 may introduce over-adjustment because diabetes mellitus, 
hypertension, HDLc, and triglycerides could be intermediaries in the causal pathway between 
obesity and coronary atherosclerosis.1 Therefore, we considered these models as exploratory but 
their use as justifiable with an aim to examine strength of association of BMI relative to these 
risk factors.1  We performed post hoc analyses examining relationship of waist circumference, a 
measure of abdominal obesity, with CAC following the same analytical frames as described 
above. 
  
We conducted a sensitivity analysis, excluding those participants who reported use of 
medication(s) for elevated blood pressure, dyslipidemia, or diabetes (models 1 through 4) as such 
treatment may influence both the exposure (obesity) and the outcome (CAC), possibly obscuring 
the true association between them. A P value of <0.05 was considered significant. All statistical 
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tests were two-sided. SAS software (ver 9.1.3; SAS Institute, Inc., Cary, North Carolina) was 
used for all statistical analyses. 
 
Results 
Table 1 shows the characteristics of the participants according to ethnic groups. While average 
height was similar (170 cm) among three groups (JJ, KN, JA), levels of both BMI and waist 
circumference in JA were greater than JJ or KN (Asian groups) and similar to UW. As compared 
to JA or UW (US groups), Asian groups tended to have more smokers, less medication users for 
elevated blood pressure and for blood lipids. CAC was less prevalent in the Asian groups than 
the US groups. 
 
Table 2 shows the results of the tertile analyses. Despite their absolute differences in BMI, the 
crude prevalence (%) of CAC increased monotonically across the BMI tertiles in all ethnic 
groups. The positive relation remained after adjusting for risk factors except for JA as shown in 
Figure. The logistic regression revealed the overall similar positive trend across the BMI tertiles 
throughout the models. Table 3 shows magnitudes of association of BMI and other risk factors 
with CAC within each ethnic group after adjusting for age, smoking, alcohol, lipids, diabetes 
mellitus, and hypertension (model 4). BMI was significantly positively associated with prevalent 
CAC in JJ, KN, and UW, but not in JA. The magnitudes of association of BMI were as strong as 
those of age or LDLc: ORs of prevalent CAC per 1 ethnic-specific SD increase in BMI (SD 
2.7-4.3kg/m2) ranged from 1.24 to 1.87 across the four groups, while ORs per 1 SD increase in 
age (SD 2.8 years in all groups) ranged from 1.01 to 1.82, and ORs per 1 SD increase in LDLc 
(SD 0.83-0.93 mmol/L) ranged from 1.15 to 1.60. Among other risk factors, current smoking and 
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use of lipid medication were associated with prevalent CAC, although the associations were not 
always statistically significant. Results of the sensitivity analysis excluding medication users for 
hypertension, diabetes or dyslipidemia (n=1015) were similar to the main results (data not 
shown).  
 
With regard to relation between waist circumference and CAC, overall trend was similar but less 
strong and less consistent across the ethnic groups compared to those of BMI. (Supplementary 
Tables S1, S2). We observed a graded increase in prevalent CAC across tertiles of waist 
circumference only among JJ (Supplementary FigureS1). Ethnic-specific Pearson’s correlation 
coefficients between waist circumference and BMI were 0.90 for JJ, 0.84 for KN, 0.91 for JA 
and 0.89 for UW (all p-values <0.001). 
 
Discussion 
This study demonstrated that obesity, measured by BMI, was positively and independently 
associated with prevalent CAC in multi-ethnic population samples of 1,212 men aged 40-49 
year-old asymptomatic individuals with no history of clinical cardiovascular disease, despite 
their absolute difference in BMI levels. 
 
CAC is a marker for coronary atherosclerosis, shown to be related to plaque burden of the 
coronary artery.6, 7 However, only limited numbers of studies examined the relationship between 
obesity and CAC with conflicting results: some reported a positive and independent association,9, 
10, 14, 17 while others showed a null 9, 11-13, 15, or even an inverse association.18 Furthermore, most 
of such studies were conducted in Western populations, in which obesity and CHD are more 
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prevalent relative to other populations such as East Asians.19-22 Examining a dose-response of 
BMI on a health outcome could be important given a recent meta-analysis questioning an 
increased risk of death among those overweight to mildly obese individuals defined by BMI.32 
Nevertheless, a dose-response of BMI on CAC was examined only in the Rotterdam Coronary 
Calcification Study in the Netherlands, to our knowledge, in which a positive association 
between BMI and CAC was reported, and the average BMI of the male participants was 26.5 
kg/m2. 10 Consistent with the Rotterdam study, we observed a positive dose-response of BMI on 
prevalent CAC in JJ, KN, and UW but not in JA in the tertile analyses. The overall strength of 
association of BMI in all groups except for JA was almost similar to that of age, which is known 
to be a significant determinant of CAC among various age ranges of a population.10, 14, 17 
Importantly, we demonstrated this association not only among a high-BMI population sample (i.e. 
UW: average BMI≃28 kg/m2) but also in low-BMI population samples (JJ and KN, average 
BMI≃24kg/m2).  
 
In multivariable logistic regression, we observed a strong association of continuous BMI with 
CAC in most groups, even with adjustment for risk factors that are related to obesity, such as 
diabetes mellitus, hypertension, and lipid levels. While many researchers consider obesity as an 
independent risk factor for clinical CHD, others remain skeptical about this view, believing that 
the effects of obesity are indirect, and only mediated by established risk factors such as those 
mentioned above.1, 2 However, given the observed independent association of BMI with CAC 
across the wide range of BMI in multi-ethnic groups, our results suggest that obesity plays an 
important role from the subclinical stage of coronary atherosclerosis independent of the 
conventional risk factors. Other studies have reported similar results to ours.10, 12, 17, 33 This 
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statistical independence may be a reflection of multiple mechanisms obesity operates in the 
pathogenesis of atherosclerosis, including low grade inflammation, prothrombotic state, insulin 
resistance, locally released cytokines from ectopic fat tissue, and endothelial dysfunction.1, 34, 35 
 
Compared to some studies reporting no significant association of obesity with CAC, we studied 
relatively younger adults within a narrower age range. The average age of our study sample was 
44.8 to 46.1 (SD of 2.8 in all groups) years, whereas the corresponding average ages (SD) were 
51.8 (10.6),11 56.4 (8.2),12 62.9 (10.3)9 years for population-based studies reporting a null 
association. The association between obesity and CAC may differ by age18, and a role of obesity 
may be more important in younger adults compared to older adults.36 Therefore, analysis 
combining a wide age range may lead to mixed results. 
 
It remains unclear as to why a positive association between BMI and CAC was obscured in JA 
compared to other groups. However, to some extent even in JA, we observed increased trend of 
crude prevalence and adjusted OR (models 1 and 4) for prevalent CAC across BMI tertiles (table 
2). We cannot reject the possibility that the obscured trend may be due to a chance.  
 
Overall, we observed a positive association between waist circumference and CAC, which is 
consistent with other studies.37-39 While the observed association of waist circumference with 
CAC was not as strong as that of BMI in our study, the opposite was true in another study.39 
Conceptually, waist circumference is deemed to be superior to BMI in predicting 
cardiometabolic risks because the former is a measure of abdominal obesity while the latter is a 
measure of total obesity. However, literature is inconsistent regarding the relative impact of these 
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measures of obesity on cardiometabolic risk, atherosclerosis, and CVD, which may be attributed 
to differences in the population characteristics studied.1 In parallel, it remains uncertain whether 
BMI or waist circumference more strongly contributes to CAC. 
 
Our data has shown that prevalence of CAC in Asian groups (JJ and KN) were lower than in US 
(UW and JA) groups. The current study does not intend to explore factors responsible for the 
difference in absolute prevalence of CAC among ethnic groups or countries, only to analyze the 
association between CAC and BMI. However, we previously reported differences in prevalent 
CAC between JJ versus JA23 and JJ versus UW,24 and explored factors that may contribute to 
such differences including marine n-3 fatty acids25 and other factors.40 
 
Cautions are needed in interpreting our results. First, the generalizability of the findings is 
limited to men aged 40 to 49 years. Second, it is known that obese individuals tend to have more 
image noise on electron-beam computed tomography.41 Thus, observed prevalence of CAC may 
be overestimated particularly among UW and JA due to their higher BMI levels. Third, 
cross-sectional nature of our study did not demonstrate a temporal relation of obesity resulting in 
increase in CAC prevalence, although many studies have showed that obesity predicts future 
clinical CHD. Strengths of the study include standardized methods that we employed in 
evaluating pertinent measures including CAC, BMI, and laboratory data. Other strengths include 
comparison of multi-ethnic groups with different background levels of CHD and obesity. As a 
result we observed a wide range of exposures (BMI) and outcomes (CAC), which is desirable in 
assessing a relationship between the two. 
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In conclusion, we found that obesity, measured by BMI, was positively associated with prevalent 
CAC in multi-ethnic groups of men aged 40-49 years free of cardiovascular disease despite 
absolute difference in BMI and CAC levels, and that the association was independent of 
conventional risk factors. The finding suggests that obesity may play an important role from the 
subclinical stage of coronary atherosclerosis among men in this age range, regardless of ethnicity 
and the level of BMI. 
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Table 1. Characteristics of Male Participants Aged 40-49 years 
                   
 
Japanese  
(n=310) 
Koreans  
(n=294) 
Japanese-Americans 
(n=300) 
US Whites 
(n=308) 
   Mean SD Mean SD Mean SD Mean SD 
Age, years 45.1 2.8  44.8 2.8  46.1 2.8  45.0 2.8  
Height, cm 170 6  170 5  170 6  180 6  
Weight, kg 68.7 10.0  71.1 8.9  80.2 14.1  90.4 14.9  
BMI,a kg/m2 23.7 3.1  24.7 2.7  27.9 4.3  27.9 4.2  
Waist circumference (cm) 85.2 8.1  83.3 7.0  93.7 11.0  98.7 11.6  
SBP, mmHg 125 16  122 14  128 13  122 11  
Glucose, mmol/Lb 5.93 1.04 5.71 1.01 6.22 1.17 5.64 0.85 
Total cholesterol, 
mmol/Lb 5.63 0.93 5.01 0.88 5.36 0.95 5.5 0.97 
LDLc, mmol/Lb 3.43 0.93 3.01 0.83 3.15 0.85 3.49 0.87 
HDLc, mmol/Lb 1.4 0.35 1.19 0.30  1.31 0.32 1.24 0.33 
Triglycerides,c mmol/Lb 1.55 (1.18-2.06) 1.53 (1.10-2.28) 1.59 (1.07-2.55) 1.46 (1.05-2.10)
Smoking, % 
never 17% 26% 66% 73% 
past 34% 36% 22% 19% 
current 49% 38% 13% 7% 
Alcohol drinking, % 
never 31% 48% 48% 47% 
past 2% 7% 14% 8% 
current 68% 45% 38% 44% 
Medication use for, % 
elevated blood pressure 6% 5% 20% 9% 
elevated lipids 4% 1% 23% 12% 
18 
 
diabetes mellitus 2% 0.3% 6% 1% 
Agatston scorec 0 (0-2) 0 (0-2) 0 (0-34) 1 (0-12) 
Prevalent CAC,d % 11.7% 10.9% 32.0% 26.1% 
Abbreviations: BMI, body mass index; CAC; coronary artery calcification; HDLc, high density lipoprotein cholesterol; 
LDLc, low density lipoprotein cholesterol; SBP, systolic blood pressure; SD, standard deviation.    
a BMI: weight (kg)/height2 (m) 
b The conversion factors from (mmol/L) to (mg/dL) for glucose, total cholesterol, LDLc, HDLc, and triglycerides are 
18.02, 38.61, 38.61, 38.61, and 88.50, respectively. 
c Values for triglycerides and Agatston score were given in median and inter-quartile rage in parenthesis 
d Prevalent CAC was defined as Agatston ≥ 10.  
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Table 2. Crude Prevalence of CAC, and Adjusted Odds Ratio for Prevalent CAC according to BMI tertile in Male Participants 
of Aged 40-49 years 
  
        
    
BMIa (kg/m2) 
No. 
Prevalent 
CACb 
Adjustedc odds ratio for  
prevalent CACb 
    
Median  (IQR) 
Model 
1 
Model 
2 
Model 
3 
Model 
4 
Japanese 
     
 
T1 21.0  ( 19.8 21.7 ) 103 7 (6.8%) ref. ref. ref. ref. 
 
T2 23.4  ( 23.0 23.9 ) 104 10 (9.6%) 1.53  1.58 1.50 1.70 
 
T3 26.6  ( 25.3 28.3 ) 103 19 (18.4%) 3.39  3.45 3.30 4.01 
Koreans 
         
 
T1 22.3  ( 21.4 23.1 ) 98 6 (6.1%) ref. ref. ref. ref. 
 
T2 24.4  ( 24.1 25.0 ) 98 11 (11.2%) 1.94  1.60 1.56 1.48 
 
T3 27.1  ( 26.3 28.2 ) 98 15 (15.3%) 2.77  2.38 2.17 1.92 
Japanese-Americans 
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T1 23.6  ( 22.7 24.7 ) 100 27 (27.0%) ref. ref. ref. ref. 
 
T2 27.4  ( 26.5 28.3 ) 100 30 (30.0%) 1.19  1.00 0.96 1.12 
 
T3 31.9  ( 30.3 34.0 ) 100 39 (39.0%) 1.75  1.57 1.38 1.59 
US Whites 
         
 
T1 24.3  ( 23.0 24.8 ) 103 15 (14.6%) ref. ref. ref. ref. 
 
T2 27.1  ( 26.4 28.0 ) 102 24 (23.5%) 1.87  1.57 1.48 1.52 
 
T3 31.9  ( 30.2 33.6 ) 103 42 (40.8%) 3.85  3.39 3.10 3.01 
Abbreviations: BMI, body mass index; CAC, coronary artery calcium; IQR, inter-quartile range; HDLc, high 
density lipoprotein cholesterol; LDLc, low density lipoprotein cholesterol; lnTG, natural log transformed 
value of triglycerides; T1, T2, T3 denotes first, second, and third tertile, respectively;  ref., reference. 
a BMI: weight (kg)/height2 (m) 
b Prevalent CAC was defined as Agatston score ≥ 10. 
c Model 1 adjusted for age (years). Model 2 further adjusted for smoking (never, past, current), alcohol 
drinking (never, past, current <23g/day, current ≥23g/day), serum level of LDLc, use of lipid medication(s) 
(yes/no). Model 3 further adjusted for diabetes mellitus (yes/no), hypertension (yes/no). Model 4 further 
adjusted for serum levels of HDLc and lnTG. Diabetes mellitus was defined as use of anti-diabetic 
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medication(s) or fasting glucose ≥7.0mmol/L (126mg/dL). Hypertension was defined as use of 
anti-hypertensive medication(s) or systolic blood pressure ≥140mmHg or diastolic blood pressure ≥90mmHg.
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Table 3. Adjusted Odds Ratios of Prevalent CACa in Male Participants Aged 40-49 years 
                       
  
Japanese 
 (n=310, prevalent CACa=36) 
Koreans  
(n=294, prevalent CACa=32) 
Adjusting covariates 1SD ORb (95%CI) Pc 1SD ORb (95%CI) Pc 
Age per 1SD (yrs) 2.8 1.82 ( 1.16 2.85 ) <0.01 2.8  1.01 ( 0.67 1.51 ) 0.97 
BMIa per 1SD (kg/m2) 3.1 1.87 ( 1.22 2.86 ) <0.01 2.7  1.56 ( 1.02 2.38 ) 0.04 
LDLc per 1SD (mmol/L) 0.93 1.60 ( 1.06 2.42 ) 0.02 0.83  1.54 ( 1.03 2.31 ) 0.03 
HDLc per 1SD (mmol/L) 0.35 1.31 ( 0.82 2.08 ) 0.26 0.30  1.10 ( 0.68 1.79 ) 0.69 
lnTG (mmol/L) per 1SD 0.46 0.99 ( 0.65 1.50 ) 0.95 0.53  1.17 ( 0.74 1.85 ) 0.50 
Lipid medication use - 2.35 ( 0.46 11.96 ) 0.30 - 4.32 ( 0.49 37.99 ) 0.19 
Diabetes mellitus - 2.15 ( 0.60 7.73 ) 0.24 - 2.58 ( 0.81 8.20 ) 0.11 
Hypertension - 0.66 ( 0.25 1.71 ) 0.39 - 1.31 ( 0.44 3.87 ) 0.63 
Smoking (ref. never) 
          
 
past - 1.36 ( 0.32 5.69 ) 0.68 - 0.74 ( 0.25 2.19 ) 0.58 
current - 2.77 ( 0.71 10.81 ) 0.14 - 0.86 ( 0.29 2.53 ) 0.78 
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Alcohol drinking (ref. never) 
         
 
past - 2.33 ( 0.19 28.54 ) 0.51 - d ( - - ) - 
current, <23g/day - 0.60 ( 0.18 1.95 ) 0.39 - 1.70 ( 0.50 5.78 ) 0.40 
current, ≥23g/day - 1.28 ( 0.50 3.27 ) 0.61 - 2.22 ( 0.84 5.90 ) 0.11 
Japanese Americans  
(n=299,e prevalent CACa=95) 
US-Whites  
(n=308, prevalent CACa=81) 
Adjusting covariates 1SD ORb (95%CI) Pc 1SD ORb (95%CI) Pc 
Age per 1SD (yrs) 2.8 1.50 ( 1.11 2.01 ) <0.01 2.8  1.71 ( 1.26 2.32 ) <0.01
BMI per 1SD (kg/m2) 4.3 1.24 ( 0.91 1.69 ) 0.18 4.2  1.70 ( 1.23 2.34 ) <0.01
LDLc per 1SD (mmol/L) 0.85 1.15 ( 0.86 1.56 ) 0.35 0.87  1.28 ( 0.95 1.73 ) 0.11 
HDLc per 1SD (mmol/L) 0.32 1.24 ( 0.91 1.69 ) 0.18 0.33  0.77 ( 0.52 1.14 ) 0.19 
lnTG (mmol/L) per 1SD 0.61 1.02 ( 0.75 1.37 ) 0.92 0.51  0.83 ( 0.59 1.18 ) 0.30 
Lipid medication - 1.73 ( 0.88 3.43 ) 0.11 - 3.26 ( 1.47 7.23 ) <0.01
Diabetes mellitus - 1.46 ( 0.66 3.26 ) 0.35 - 1.73 ( 0.41 7.36 ) 0.46 
Hypertension - 1.11 ( 0.59 2.10 ) 0.74 - 1.16 ( 0.54 2.52 ) 0.70 
Smoking (ref. never) 
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past - 1.14 ( 0.60 2.16 ) 0.69 - 1.58 ( 0.78 3.21 ) 0.21 
current - 2.64 ( 1.21 5.74 ) 0.01 - 2.08 ( 0.73 5.90 ) 0.17 
Alcohol drinking (ref. never) 
         
 
past - 1.08 ( 0.48 2.42 ) 0.86 - 0.82 ( 0.28 2.41 ) 0.72 
current, <23g/day - 0.84 ( 0.32 2.25 ) 0.73 - 0.97 ( 0.48 1.94 ) 0.93 
current, ≥23g/day - 1.75 ( 0.90 3.37 ) 0.10 - 1.17 ( 0.49 2.82 ) 0.72 
Abbreviations: BMI, body mass index; CAC, coronary artery calcium; HDLc, high density lipoprotein cholesterol; 
LDLc, low density lipoprotein cholesterol;  lnTG, natural log transformed value of triglycerides; OR, odds ratio; SD, 
standard deviation; 95%CI, 95% confidence interval.  
a Prevalent CAC was defined as Agatston score≥10. 
b For a continuous variable, odds ratio was expressed per one SD (ethnic group specific SD) increase in the value. 
Odds ratio was adjusted for age (years), serum levels (continuous) of LDLc, HDLc, and lnTG, use of lipid medication 
(yes/no), diabetes mellitus (yes/no), hypertension (yes/no), smoking (never, past, current), and alcohol drinking (never, 
past, current <23g/day, current ≥23g/day) (Model 4). Diabetes mellitus was defined as use of anti-diabetic 
medication(s) or fasting glucose ≥7.0mmol/L (126mg/dL).  Hypertension was defined as use of anti-hypertensive 
medication(s) or systolic blood pressure ≥140mmHg or diastolic blood pressure ≥90mmHg. 
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c P-values were two-sided. 
d The estimates were unable to obtain because no participants in this category had prevalent CAC. 
e One participant was excluded in this analysis due to missing HDLc. 
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Figure title and legend 
Figure. Adjusted prevalence of CAC across BMI tertiles in four ethnic groups of the male 
participants aged 40-49 years 
 
Legend: Each knot represents median BMI (kg/m2) on X-axis and corresponding adjusted CAC 
prevalence (%) on Y-axis for each group-specific tertile of BMI.  
Prevalence of CAC was defined as Agatston score ≥10, and adjusted for age (year), smoking 
status (never, past, current), alcohol drinking status (never, past, current with <23g/day of alcohol, 
current with ≥23g/day of alcohol), serum LDLc level (continuous) and use of lipid medication 
(yes/no) (model 2). 
Abbreviations: BMI, body mass index; CAC, Coronary artery calcium; LDLc, low density 
lipoprotein cholesterol. 
 
 
